Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05552573
What this trial is testing

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 100
Testing effectiveness (Phase 2)UnknownNCT05248373
What this trial is testing

Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 400
Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Not applicableStudy completedNCT05998824
What this trial is testing

COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseCOVID-19 VaccineVaccine Hesitancy
Duke University 33
Not applicableStudy completedNCT05612386
What this trial is testing

Planning Message Recommending Same Time/Location as Last Vaccine

Who this might be right for
COVID-19
University of Pennsylvania 520,000
Testing effectiveness (Phase 2)Study completedNCT04764422
What this trial is testing

Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand

Who this might be right for
Covid-19SARS PneumoniaPneumonia, Viral+1 more
Mahidol University 455
Early research (Phase 1)Ended earlyNCT04627675
What this trial is testing

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)

Who this might be right for
SARS-CoV-2
Providence Health & Services 16
Not applicableStudy completedNCT05139992
What this trial is testing

COVID-19 Vaccine Response in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseCOVID-19
ASH Research Collaborative 59
Testing effectiveness (Phase 2)Study completedNCT05142553
What this trial is testing

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 887
Testing effectiveness (Phase 2)Study completedNCT04447781
What this trial is testing

Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19

Who this might be right for
Coronavirus InfectionSARS-CoV 2
International Vaccine Institute 79
Post-approval studies (Phase 4)UnknownNCT05012800
What this trial is testing

Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults

Who this might be right for
COVID-19 VaccineOlder Adults
Beijing 302 Hospital 300
Testing effectiveness (Phase 2)UnknownNCT05409300
What this trial is testing

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Who this might be right for
COVID-19Vaccine Adverse ReactionSars-CoV-2 Infection+1 more
ANRS, Emerging Infectious Diseases 200
Testing effectiveness (Phase 2)Study completedNCT05518487
What this trial is testing

COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

Who this might be right for
COVID-19Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 15
Testing effectiveness (Phase 2)Study completedNCT06237049
What this trial is testing

Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

Who this might be right for
Influenza, HumanSARS-CoV-2 InfectionCOVID-19
Pfizer 644
Early research (Phase 1)Study completedNCT05938075
What this trial is testing

Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa

Who this might be right for
SARS-CoVSARS-CoV-2
Vaccine Company, Inc. 130
Testing effectiveness (Phase 2)Study completedNCT05770180
What this trial is testing

Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 450
Post-approval studies (Phase 4)Study completedNCT05313646
What this trial is testing

Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 1,050
Not applicableStudy completedNCT05047822
What this trial is testing

Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

Who this might be right for
Covid-19 Infection
AstraZeneca 18,373,714
Large-scale testing (Phase 3)Study completedNCT05279456
What this trial is testing

A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

Who this might be right for
COVID-19
Vaxine Pty Ltd 39
Testing effectiveness (Phase 2)Ended earlyNCT05788185
What this trial is testing

Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals

Who this might be right for
Infectious DiseaseCOVID-19
RVAC Medicines (US), Inc. 24
Next Page